Trial | NCT00033215  Report issue

Official Title

A Phase 1 Study of S-3304 in Patients With Solid Tumors

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    s-3304 ...

  • Study Participants

    32
To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population
Study Started
Nov 30
2001
Primary Completion
Feb 13
2003
Study Completion
Mar 12
2003
Last Update
Apr 26
2018

Drug S-3304

Criteria 

Inclusion criteria:

Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)
Must be able to tolerate oral medication Exclusion criteria
Patients with other serious illnesses
Patients who are receiving treatments
No Results Posted